RNTX RNTX Employee Related Expenses — Research And Development Expense
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by RNTX in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about RNTX's employee related expenses — research and development expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is RNTX's employee related expenses — research and development expense?
- RNTX (RNTX) reported employee related expenses — research and development expense of $500K in Q1 2026.
- How has RNTX's employee related expenses — research and development expense changed year-over-year?
- RNTX's employee related expenses — research and development expense decreased by 19.6% year-over-year, from $622K to $500K.
- What is the long-term trend for RNTX's employee related expenses — research and development expense?
- Over 2 years (2023 to 2025), RNTX's employee related expenses — research and development expense has grown at a 32.1% compound annual growth rate (CAGR), from $1.21M to $2.12M.
- What does employee related expenses — research and development expense mean?
- This metric represents the portion of total personnel-related costs specifically allocated to research and development activities. It captures the investment in human capital required to advance clinical-stage drug candidates and support scientific innovation. Monitoring this expense helps investors assess the company's commitment to its pipeline development and the efficiency of its R&D workforce.